This memorandum provides guidance on the implementation of the nondiscretionary infant formula cost containment provisions of PL 108-265, the Child Nutrition and WIC Reauthorization Act of 2004.
Authorized by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), the prescription drug discount card provides Medicare beneficiaries with negotiated prices that should be lower than the regular price of prescription drugs.
This policy memorandum provides guidance to state and local agencies on the WIC Racial/Ethnic Data Collection.
This memorandum provides guidance concerning allowable FMNP costs that may be covered with federal WIC funds. It is intended to promote accuracy and uniformity in the application of allowable cost principles to decisions about FMNP related costs, as state agencies seek to maximize federal funding.